title: Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada.
authors.affiliation: Internal Medicine 1, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan, sugimoto@med.shimane-u.ac.jp.
authors.forename: T
authors.initials: T
authors.lastname: Sugimoto
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
authors.forename: Y
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Y
authors.initials: Y
authors.lastname: Isogai
authors.forename: M
authors.initials: M
authors.lastname: Shiraki
mesh_terms: D050071:Bone Density Conservation Agents / Q000494:pharmacology*; D016723:Bone Remodeling / Q000187:drug effects*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000503:physiopathology*; D019379:Teriparatide / Q000494:pharmacology*
chemical_list: D050071:Bone Density Conservation Agents; D019379:Teriparatide